EUVIMEDObjevte EUVIMED
Crossref

The Perspectives and Experiences of Prospective Parents Declining Diagnostic Prenatal Genome Sequencing in Continuing Pregnancies With Fetal Structural Anomalies

Lisa S Weingarten iD, Allison Rosenbaum iD, Jessica de Voest iD, Stephanie Galloway, Jessica L Giordano iD, Samantha Stover iD, Lauren E Westerfield iD, Grant Bonesteele iD, Kelly L Gilmore iD, Leandra Tolusso, Beatrix Wong iD, A Theresa Wittman iD and 9 more

Prenatal Diagnosis · 2026

DOI: 10.1002/pd.70034 ↗

At a glance

Journal article in Prenatal Diagnosis, 2026. Written by Lisa S Weingarten and 20 co-authors. Institution: Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA. Major MEDLINE topics: Parents, Prenatal Diagnosis, Congenital Abnormalities. Cited 4 times so far (Crossref); 20 references. Funded by: NICHD NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

This study evaluates an understudied perspective: the experiences of prospective parents who decline prenatal genome sequencing (pGS) for continuing pregnancies with fetal structural anomalies.

Method

We recruited a total cohort of 300 parents of 150 pregnancies who declined pGS, including 33 individuals who underwent an invasive procedure. These parents were invited to participate in a semi‐structured interview between 1 and 15 months post‐partum. We used Thematic Analysis to code and analyze interviews.

Results

We interviewed 22 parents of 16 pregnancies. Reasons for declining testing included risks of invasive procedures ( n = 19, 86%), lack of prenatally actionable findings ( n = 17, 77%), unclear benefits of testing ( n = 9, 41%), satisfaction with previous testing ( n = 11, 50%), expected low diagnostic yield ( n = 13, 59%), emotional and information overload ( n = 11, 50%), intolerance of uncertainty ( n = 13, 59%), and privacy concerns ( n = 5, 23%). Most individuals indicated that, if available, they would elect non‐invasive prenatal sequencing. Overall, participants were satisfied with their choice to decline pGS and had no regrets postnatally.

Conclusions

The reasons individuals declined pGS included medical and emotional risks of testing and an understanding of potential results and their utility. To address these concerns, pretest genetic counseling should include the probability of diagnostic results, impact of prenatal/perinatal management, consideration of uncertain results, privacy concerns, and benefits and limitations of postnatal testing. Non‐invasive prenatal sequencing, currently under investigation in research settings, may be an alternative future option, but will not address all concerns. Given that our cohort was small and homogenous, lacked cost burden, excluded terminated pregnancies, and included no postnatal genetic diagnoses, further research is needed to confirm that these findings are generalizable.

Subjects

MeSH terms (MEDLINE)

ParentsPrenatal DiagnosisCongenital AbnormalitiesHumansFemalePregnancyAdultProspective StudiesWhole Genome SequencingMaleGenetic Testing

Authors and institutions

  • Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA.
  • Columbia University Vagelos College of Physicians & Surgeons, New York, New York, USA.
  • George Washington University Biostatistics Center, Washington, District of Columbia, USA.
  • Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, New York, USA.
  • Department of Obstetrics & Gynecology and Molecular & Human Genetics, Baylor College of Medicine, and Texas Children's Hospital, Houston, Texas, USA.
  • Department of Obstetrics & Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID profiles: Lisa S Weingarten, Allison Rosenbaum, Jessica de Voest, Jessica L Giordano, Samantha Stover, Lauren E Westerfield, Grant Bonesteele, Kelly L Gilmore, Beatrix Wong, A Theresa Wittman, Daniel T Swarr, Anthony Johnson, Ignatia B Van den Veyver, Neeta L Vora, Aaron B Caughey, Wendy K Chung

Funding

  • NICHD NIH HHS

Cite

APA

Weingarten, L. S., Rosenbaum, A., de Voest, J., Galloway, S., Giordano, J. L., Stover, S., Westerfield, L. E., Bonesteele, G., Gilmore, K. L., Tolusso, L., Wong, B., Wittman, A. T., Swarr, D. T., Leslie, N., Johnson, A., Van den Veyver, I. B., Vora, N. L., Clifton, R. G., Caughey, A. B., …, & Chung, W. K. (2026). The Perspectives and Experiences of Prospective Parents Declining Diagnostic Prenatal Genome Sequencing in Continuing Pregnancies With Fetal Structural Anomalies. Prenatal Diagnosis. https://doi.org/10.1002/pd.70034

Vancouver

Weingarten LS, Rosenbaum A, de Voest J, Galloway S, Giordano JL, Stover S, et al. The Perspectives and Experiences of Prospective Parents Declining Diagnostic Prenatal Genome Sequencing in Continuing Pregnancies With Fetal Structural Anomalies. Prenatal Diagnosis. 2026. doi:10.1002/pd.70034

BibTeX
@article{Weingarten2026,
  author = {Weingarten, Lisa S and Rosenbaum, Allison and de Voest, Jessica and Galloway, Stephanie and Giordano, Jessica L and Stover, Samantha and Westerfield, Lauren E and Bonesteele, Grant and Gilmore, Kelly L and Tolusso, Leandra and Wong, Beatrix and Wittman, A Theresa and Swarr, Daniel T and Leslie, Nancy and Johnson, Anthony and Van den Veyver, Ignatia B and Vora, Neeta L and Clifton, Rebecca G and Caughey, Aaron B and Wapner, Ronald J and Chung, Wendy K},
  title = {The Perspectives and Experiences of Prospective Parents Declining Diagnostic Prenatal Genome Sequencing in Continuing Pregnancies With Fetal Structural Anomalies},
  journal = {Prenatal Diagnosis},
  year = {2026},
  doi = {10.1002/pd.70034}
}
Start for free →